 |
Parvovirus B19 (recombinant VP1 and VP2; S.frugiperda cells) vaccine |
|---|---|
| Trade Name | Medi-491 |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 1999-05-07 00:00:00 |
| Sponsor | MedImmune, Inc.;35 West Watkins Mill Rd.;Gaithersburg, Maryland, 20878 |
Related Access Program